Empagliflozin patent expiration in India leads to affordable treatment for diabetes, heart failure, and kidney disease.
Discover preclinical studies that indicate that empagliflozin reduces liver fat, improves liver function markers, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback